The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Feasibility of combining EGFR- and VEGF(R)-targeted agents in colorectal cancer.
Annette K Larsen
Disclosure not yet available
Virginie Poindessous
Disclosure not yet available
Djamila Ouaret
Disclosure not yet available
Karima El Ouadrani
Disclosure not yet available
Virginie F Megalophonos
Disclosure not yet available
Aude Batistella
Disclosure not yet available
Amélie Petitprez
Disclosure not yet available
Alexandre E Escargueil
Disclosure not yet available
Christophe Tournigand
Disclosure not yet available
Aimery De Gramont
Disclosure not yet available